Skip to content Skip to footer

Current Treatment Options for Multiple Sclerosis

Here’s a chart comparing the administration and dosing frequency of various Multiple Sclerosis medications:

Medication Administration Dosing Frequency
Interferon-Beta Products
– Avonex (interferon beta-1a) Intramuscular injection Once a week
Betaseron (interferon beta-1b) Subcutaneous injection Every other day
– Extavia (interferon beta-1b) Subcutaneous injection Every other day
Glatiramer Acetate- Copaxone (glatiramer acetate) Subcutaneous injection Daily
Sphingosine-1-Phosphate Receptor Modulators
– Gilenya (fingolimod) Oral capsule Once a day
– Mayzent (siponimod) Oral tablet Once a day
Monoclonal Antibodies
– Tysabri (natalizumab) Intravenous infusion Every 4-6 weeks
– Ocrevus (ocrelizumab) Intravenous infusion Initially, every 6 months
– Lemtrada (alemtuzumab) Intravenous infusion 5 consecutive days, then
3 consecutive days after
Oral Medications
– Tecfidera (dimethyl fumarate) Oral capsule Twice a day
– Aubagio (teriflunomide) Oral tablet Once a day
– Vumerity (diroximel fumarate) Oral capsule Twice a day
Immune System Modulators
– Mavenclad (cladribine) Oral tablet 2 courses over 2 years
– Zeposia (ozanimod) Oral capsule Once a day

Please note that dosing frequencies and administration methods may vary based on individual patient profiles and the specific recommendations of healthcare providers. Always consult with a healthcare professional for accurate and personalized treatment information.